GLP-1 microdosing for weight loss: Insights from experts on pros and cons
A growing trend in the use of GLP-1 receptor agonists for weight loss involves a practice known as "microdosing." This experimental approach, which entails taking a lower-than-prescribed dose of these popular medications, is being adopted by some patients in an attempt to manage side effects, reduce costs, or achieve more gradual weight loss. However, this strategy is not without significant debate, and medical professionals are carefully weighing the potential benefits against a number of substantial risks.The appeal of microdosing is primarily driven by a desire to mitigate the common, and often severe, gastrointestinal side effects associated with the standard therapeutic…
